The Future of Antibody Discovery

Optimized for diversity and fitness, the SuperHuman Antibody Library from Distributed Bio is revolutionizing the way we discover therapeutic antibodies. In this animated case study, learn how a scientist and his team use the SuperHuman library to identify hundreds of hits against his challenging target. Promising an easier development process, hits are high affinity, non-immunogenic, aggregation resistant and thermostable, and many of them cross-react with mice, nonhuman primates and human antigens, allowing them to enter the clinic faster than the competition. Charles River combines Distributed Bio’s unique antibody discovery platform with fully integrated discovery services for an optimal journey through development. Learn more here: https://bit.ly/3sjN4HB  


For over 70 years, Charles River has provided essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe, helping to accelerate their research and drug development efforts. With over 90 sites globally, we’re ready to tackle your product’s most unique challenges. Our focus on timeliness and accuracy in every stage of drug development means you can count on us to deliver reliable results – every step of the way.   

Visit our website to learn more about our portfolio and how we can support your research.   https://bit.ly/2RTdGOU

• #science_technology
• #antibody_screening
• #antibody_library
• #distributed_bio
• #therapeutic_antibodies_contract_research_organization
• #cro
• #charles_river_labs
• #drug_development